Calcium Homeostasis: How Parathyroid Hormone Balances Blood Calcium

Why Blood Calcium Must Stay in a Narrow Range

Calcium is far more than a bone-building mineral. Only about 1% of the body's total calcium circulates in blood and extracellular fluid, but that fraction is essential for excitable tissue function. Calcium ions control the voltage threshold at which nerve and muscle cell membranes fire: low extracellular calcium makes membranes more excitable, because calcium normally stabilizes sodium channels and prevents them from opening prematurely. When calcium falls, these channels become abnormally leaky to sodium, nerves fire spontaneously, and muscles contract involuntarily, a condition called tetany. Calcium is also the trigger for acetylcholine release at the neuromuscular junction and for actin-myosin cross-bridge formation inside muscle fibers, meaning it is required at both ends of the signal, from nerve to muscle contraction itself. On the other side of the ledger, calcium ions are essential cofactors in the coagulation cascade, historically called "Factor IV," required for several steps that convert prothrombin to thrombin and stabilize fibrin clots. Calcium ions similarly regulate cardiac pacemaker activity and the plateau phase of the cardiac action potential, so both hypocalcemia and hypercalcemia can produce dangerous arrhythmias. Because calcium is simultaneously a structural mineral, a clotting cofactor, and a universal second messenger for excitation-contraction coupling, the body cannot tolerate large swings. The normal range of roughly 8.5 to 10.5 mg/dL (2.1 to 2.6 mmol/L) total serum calcium, with ionized calcium around 4.5 to 5.6 mg/dL (1.1 to 1.4 mmol/L), is defended by continuous hormonal surveillance rather than passive buffering alone.

PTH's Action on Bone: Mobilizing the Body's Calcium Reservoir

The skeleton stores about 99% of the body's calcium, roughly 1 to 1.2 kilograms in an adult, mostly as hydroxyapatite crystals, making bone the obvious reservoir to tap when blood calcium drops. Parathyroid hormone is secreted by chief cells within the four parathyroid glands in direct response to falling ionized calcium, detected by calcium-sensing receptors (CaSR) on the cell surface. When plasma calcium dips even slightly, CaSR activation decreases and PTH secretion rises sharply, since the relationship between calcium and PTH release is a steep inverse sigmoid, allowing rapid, sensitive correction. PTH does not directly dissolve bone; instead it binds PTH receptors on osteoblasts (bone-building cells), which respond by increasing expression of RANKL, a signaling protein that binds RANK receptors on osteoclast precursors and drives their maturation into active, bone-resorbing osteoclasts. These osteoclasts secrete acid and proteolytic enzymes that dissolve hydroxyapatite crystals, releasing calcium and phosphate into the bloodstream within hours. This indirect osteoblast-to-osteoclast signaling relay is a classic example of coupled bone remodeling. Sustained high PTH, as seen in chronic hyperparathyroidism, tips this balance toward net bone loss, weakening the skeleton over months to years and raising fracture risk, which is why chronically elevated PTH is clinically significant even though short bursts of PTH secretion are a normal, healthy part of daily calcium regulation. Interestingly, intermittent (rather than continuous) PTH exposure can actually stimulate bone formation, the principle behind teriparatide, a synthetic PTH fragment used to treat osteoporosis.

PTH's Action on the Kidney and Vitamin D Activation

Beyond bone, PTH acts on the kidneys in two complementary ways. First, it directly increases calcium reabsorption in the distal convoluted tubule, reducing the amount of calcium lost in urine and conserving what the body already has, an effect that can be measured within minutes of PTH release. Simultaneously, PTH decreases phosphate reabsorption in the proximal tubule, promoting phosphate excretion; this matters because phosphate released from resorbed bone would otherwise bind free calcium and blunt the rise in ionized calcium, so PTH's phosphaturic effect protects the net gain in usable calcium. Second, and just as critical, PTH stimulates the enzyme 1-alpha-hydroxylase in the proximal tubule, which converts 25-hydroxyvitamin D (the storage form, made in the liver from sun-exposed or dietary vitamin D) into 1,25-dihydroxyvitamin D, also called calcitriol, the biologically active hormone form. Calcitriol then travels to the small intestine, where it binds vitamin D receptors in enterocytes and dramatically upregulates the synthesis of calbindin and calcium transport channels (TRPV6), increasing active calcium absorption from ingested food. This third arm of PTH action is slower, taking hours to a couple of days to reach full effect, because it requires new protein synthesis, but it produces the largest overall increase in available calcium of the three mechanisms since dietary intake is a renewable source rather than a finite reservoir. Together, direct renal reabsorption, reduced renal phosphate retention, and vitamin D-driven intestinal absorption make the kidney a central hub of calcium regulation, not just a passive filter.

Calcitonin: The Opposing Signal from the Thyroid

While PTH raises blood calcium, calcitonin, secreted by parafollicular C cells within the thyroid gland, works in the opposite direction, lowering plasma calcium when levels rise too high, such as after a calcium-rich meal. Calcitonin directly inhibits osteoclast activity, reducing bone resorption and the release of calcium into the bloodstream, essentially the reverse of PTH's effect on the skeleton. It also modestly increases renal calcium and phosphate excretion. However, calcitonin's physiological role in adult humans is considerably weaker than PTH's, and people who have had their thyroid surgically removed (and therefore lack calcitonin entirely) typically maintain normal calcium levels, demonstrating that PTH is the dominant, non-negotiable regulator while calcitonin acts more as a fine-tuning, protective brake. Calcitonin's effects are most pronounced in children, where skeletal calcium turnover is high, and it has found clinical use as a therapeutic agent, injected or given as a nasal spray, to rapidly lower dangerously high calcium levels (hypercalcemia) or to reduce bone pain in certain bone diseases like Paget's disease. The asymmetry between these two hormones, one indispensable and steeply responsive, one auxiliary, reflects the body's evolutionary priority: dropping too low in calcium is a far more urgent and immediate threat to nerve and muscle function than transient elevations, so the system is built to defend against hypocalcemia much more aggressively than hypercalcemia.

When the System Fails: Hypoparathyroidism, Hyperparathyroidism, and Tetany

Disorders of this feedback loop produce some of the most recognizable syndromes in clinical endocrinology. In hypoparathyroidism, often caused by accidental removal or damage to the parathyroid glands during thyroid surgery, or by autoimmune destruction, PTH secretion is insufficient, so bone resorption slows, renal calcium reabsorption drops, and vitamin D activation falls. The resulting hypocalcemia produces the hallmark syndrome of tetany: muscle twitching, cramps, and in severe cases sustained, painful muscle spasm. Classic bedside signs include Chvostek's sign (tapping the facial nerve near the ear triggers facial muscle twitching) and Trousseau's sign (inflating a blood pressure cuff on the arm induces characteristic wrist and finger spasm, called carpopedal spasm), both reflecting the heightened neuromuscular excitability caused by low extracellular calcium. Severe hypocalcemia can also prolong the QT interval on an electrocardiogram and precipitate seizures or laryngospasm, a medical emergency. At the opposite extreme, primary hyperparathyroidism, most commonly caused by a benign parathyroid adenoma that secretes PTH autonomously regardless of calcium levels, produces chronic hypercalcemia. This is often summarized by the mnemonic "stones, bones, groans, and psychiatric overtones": kidney stones from excess urinary calcium, bone pain and fractures from ongoing resorption, gastrointestinal symptoms, and cognitive changes ranging from mild confusion to depression. Severe hypercalcemia can shorten the QT interval and, in extreme cases, cause coma. These paired disorders illustrate why the PTH-calcium feedback loop is not a minor housekeeping detail but a life-critical system that clinicians measure and treat with real urgency.

Frequently asked questions

Try it live

Everything above runs in your browser — open Calcium Homeostasis: How Parathyroid Hormone Balances Blood Calcium and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.